Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses. A follow-up of three patients.

Source:http://linkedlifedata.com/resource/pubmed/id/16791927

Download in:

View as

General Info

PMID
16791927